IFNB1 and breast carcinoma: In a panel of human breast cancer cell lines, PARP7i similarly showed greater-than-additive synergy with RT in driving IFNB1 expression in most models tested (Fig. 4g–h), underscoring its broad potential as an amplifier of RT-induced ISG responses.